Case Western Reserve Embarks on Innovative Path to Treat Infections of Drug-Resistant Superbugs such as MRSA without Antibiotics

Home » news » Case Western Reserve Embarks on Innovative Path to Treat Infections of Drug-Resistant Superbugs such as MRSA without Antibiotics

School of Medicine’s biochemistry department team, in partnership with Q2 Pharma, to develop antivirulence agents that disarm bacteria of deadly toxins

About the Author

View all posts by iykkv

Q2 Pharma is developing small-molecule antivirulence agents against bacterial infections.

Click here to cancel reply.

About the Author

View all posts by iykkv

Leave a Reply